'Cure' of life-threatening antiphospholipid syndrome with rituximab

被引:9
作者
Anandacoomarasamy, A. [1 ]
Gibson, J.
McGill, N.
机构
[1] Royal Prince Alfred Hosp, Dept Rheumatol, Sydney, NSW, Australia
[2] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
关键词
D O I
10.1111/j.1445-5994.2006.01113.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:474 / U10
页数:2
相关论文
共 4 条
[1]   The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura [J].
Cooper, N ;
Stasi, R ;
Cunningham-Rundles, SS ;
Feuerstein, MA ;
Leonard, JP ;
Amadori, S ;
Bussel, JB .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) :232-239
[2]  
Looney RJ, 2005, J RHEUMATOL, V32, P25
[3]   Rituximab therapy and autoimmune disorders - Prospects for anti-B cell therapy [J].
Silverman, GJ ;
Weisman, S .
ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1484-1492
[4]   Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus [J].
ten Cate, R ;
Smiers, FJ ;
Bredius, RGM ;
Lankester, AC ;
van Suijlekom-Smit, LWA ;
Huizinga, TW ;
Egeler, RM .
RHEUMATOLOGY, 2004, 43 (02) :244-245